UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Volltextzugriff (PDF)

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gastroenterology (New York, N.Y. 1943), 2007-10, Vol.133 (4), p.1099-1105

2007

Volltextzugriff (PDF)

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1730-1732

Kornbluth, Asher

2020

Volltextzugriff (PDF)

Adalimumab: Another Treatment Option for Moderate-to-Severe UC

Gastroenterology & hepatology, 2013-05, Vol.9 (5), p.321-321

Kornbluth, Asher A

2013

Volltextzugriff (PDF)

The First Endoscopy in Suspected Inflammatory Bowel Disease

Gastrointestinal endoscopy clinics of North America, 2016-10, Vol.26 (4), p.593-610

2016

Volltextzugriff (PDF)

Double balloon enteroscopy in Crohn's disease: background and current state of play

Current drug targets, 2012-09, Vol.13 (10), p.1280-1286

2012

Volltextzugriff (PDF)

Visible dysplasia: what you see is most of what you get

Gastrointestinal endoscopy, 2007-06, Vol.65 (7), p.1005-1006

Kornbluth, Asher, MD

2007

Volltextzugriff (PDF)

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Inflammatory bowel diseases, 1998-11, Vol.4 (4), p.328-329

Kornbluth, A

1998

Volltextzugriff (PDF)

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1002-1007

2012

Volltextzugriff (PDF)

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Inflammatory bowel diseases, 2010-12, Vol.16 (S1), p.S1-S11

2010

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Volltextzugriff (PDF)

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

Diseases of the colon & rectum, 2007-06, Vol.50 (6), p.825-831

2007

Volltextzugriff (PDF)

Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis

Gastroenterology & hepatology, 2015-01, Vol.11 (1), p.56-58

Kornbluth, Asher

2015

Volltextzugriff (PDF)

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S104-S105

2022

Volltextzugriff (PDF)

Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis

Gastroenterology & hepatology, 2014-12, Vol.10 (12), p.793-800

2014

Volltextzugriff (PDF)

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2513-2526

2016

Volltextzugriff (PDF)

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-03, Vol.18 (3), p.145-155

2022

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S104-S105

2022

Volltextzugriff (PDF)

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1118-1130.e3

2021

Volltextzugriff (PDF)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-599-S-599

2022

Volltextzugriff (PDF)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Gut, 2012-04, Vol.61 (4), p.535-542

2012

Volltextzugriff (PDF)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Volltextzugriff (PDF)

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis

Gastroenterology & hepatology, 2011-10, Vol.7 (10), p.677-679

Kornbluth, Asher

2011

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Aktive Filter

ThemaGastroenterology

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(75)

Publikationsform

Artikel
(111)

Sprache

Englisch
(111)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Gastroenterology & Hepatology
(40)
Gastroenterology And Hepatology
(24)
Female
(22)
Male
(21)
Adult
(18)
Crohn's Disease
(16)
Crohn Disease - Drug Therapy
(13)
Middle Aged
(13)
Ulcerative Colitis
(13)
Treatment Outcome
(12)
Biological And Medical Sciences
(10)
Inflammatory Bowel Disease
(10)
Infliximab
(10)
Medical Sciences
(10)
Colitis, Ulcerative - Drug Therapy
(8)
Inflammatory Bowel Diseases - Drug Therapy
(8)
Antibodies, Monoclonal - Therapeutic Use
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Adalimumab: Another Treatment Option for Moderate-to-Severe UC

The First Endoscopy in Suspected Inflammatory Bowel Disease

Double balloon enteroscopy in Crohn's disease: background and current state of play

Visible dysplasia: what you see is most of what you get

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis

Aktive Filter

Suchergebnisse filtern